Primary Hyperparathyroidism-Phosphaturic Mesenchymal Tumour: An Unusual Association and a Probable Syndrome
Phosphaturic Mesenchymal Tumour (PMT) is a rare and underdiagnosed tumour that causes Tumour-Induced Osteomalacia (TIO). These tumours produce Fibroblast Growth Factor-23 (FGF23), which inhibits renal tubular phosphate reabsorption, leading to hyperphosphaturia and oncogenic osteomalacia. The associ...
Saved in:
Main Authors: | Gwendolyn Fernandes, Avanika, Gloria Khumanthem |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2025-01-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://www.jcdr.net/articles/PDF/20543/75129_CE[Ra1]_F(SHU)_QC(PS_SS)_PF1(AG_SL)_PFA(IS)_PB(AG_IS)_PN(IS).pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phosphaturic mesenchymal tumor: Clinicopathological features with outcomes in 10 patients with review of literature
by: Vivek C. Parameshwar, et al.
Published: (2024-04-01) -
FGF23-related hypophosphatemia in a patient with small cell lung cancer: a case report and literature review
by: Hajime Kato, et al.
Published: (2023-10-01) -
Atraumatic bilateral subtrochanteric fracture in a young female with osteomalacia
by: Urmila Dhakad, et al.
Published: (2017-01-01) -
Comprehensive Metabolomic Profiling in Adults with X-Linked Hypophosphatemia: A Case-Control Study
by: Luis Carlos López-Romero, et al.
Published: (2024-12-01) -
Drug-induced bone disorders: A systematic review
by: Anshita Aggarwal, et al.
Published: (2019-01-01)